Surface patches on recombinant erythropoietin predict protein solubility: engineering proteins to minimise aggregation

被引:11
作者
Alejandro Carballo-Amador, M. [1 ]
McKenzie, Edward A. [2 ]
Dickson, Alan J. [3 ]
Warwicker, Jim [2 ]
机构
[1] Univ Autonoma Baja California, Fac Ciencias, Km 103 Carretera Tijuana Ensenada, Ensenada 22860, Baja California, Mexico
[2] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England
[3] Univ Manchester, Fac Sci & Engn, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
Protein solubility; Protein aggregates; Inclusion bodies; Erythropoietin; Solubility prediction; Protein expression; ESCHERICHIA-COLI; EVOLUTIONARY CONSERVATION; SOLUBLE EXPRESSION; MUTATIONS; HYDRATION; DESIGN; WATER;
D O I
10.1186/s12896-019-0520-z
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
BackgroundProtein solubility characteristics are important determinants of success for recombinant proteins in relation to expression, purification, storage and administration. Escherichia coli offers a cost-efficient expression system. An important limitation, whether for biophysical studies or industrial-scale production, is the formation of insoluble protein aggregates in the cytoplasm. Several strategies have been implemented to improve soluble expression, ranging from modification of culture conditions to inclusion of solubility-enhancing tags.ResultsSurface patch analysis has been applied to predict amino acid changes that can alter the solubility of expressed recombinant human erythropoietin (rHuEPO) in E. coli, a factor that has importance for both yield and subsequent downstream processing of recombinant proteins. A set of rHuEPO proteins (rHuEPO E13K, F48D, R150D, and F48D/R150D) was designed (from the framework of wild-type protein, rHuEPO WT, via amino acid mutations) that varied in terms of positively-charged patches. A variant predicted to promote aggregation (rHuEPO E13K) decreased solubility significantly compared to rHuEPO WT. In contrast, variants predicted to diminish aggregation (rHuEPO F48D, R150D, and F48D/R150D) increased solubility up to 60% in relation to rHuEPO WT.ConclusionsThese findings are discussed in the wider context of biophysical calculations applied to the family of EPO orthologues, yielding a diverse range of calculated values. It is suggested that combining such calculations with naturally-occurring sequence variation, and 3D model generation, could lead to a valuable tool for protein solubility design.
引用
收藏
页数:10
相关论文
共 66 条
[31]   A protein chimera strategy supports production of a model "difficult-to-express" recombinant target [J].
Hussain, Hirra ;
Fisher, David I. ;
Roth, Robert G. ;
Mark Abbott, W. ;
Carballo-Amador, Manuel Alejandro ;
Warwicker, Jim ;
Dickson, Alan J. .
FEBS LETTERS, 2018, 592 (14) :2499-2511
[32]   Codon optimization and factorial screening for enhanced soluble expression of human ciliary neurotrophic factor in Escherichia coli [J].
Itkonen, Jaakko M. ;
Urtti, Arto ;
Bird, Louise E. ;
Sarkhel, Sanjay .
BMC BIOTECHNOLOGY, 2014, 14
[33]  
JENKINS TM, 2013, P NATL ACAD SCI USA, V92, P6057
[34]   Soluble expression and partial purification of recombinant human erythropoietin from E-coli [J].
Jeong, Taeck-Hyun ;
Son, Young-Jin ;
Ryu, Han-Bong ;
Koo, Bon-Kyung ;
Jeong, Seung-Mi ;
Hoang, Phuong ;
Do, Bich Hang ;
Song, Jung-A ;
Chong, Seon-Ha ;
Robinson, Robert Charles ;
Choe, Han .
PROTEIN EXPRESSION AND PURIFICATION, 2014, 95 :211-218
[35]   Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies [J].
Jetha, Arif ;
Thorsteinson, Nels ;
Jmeian, Yazen ;
Jeganathan, Ajitha ;
Giblin, Patricia ;
Fransson, Johan .
MABS, 2018, 10 (06) :890-900
[36]  
KRANTZ SB, 1991, BLOOD, V77, P419
[37]   HYDRATION OF MACROMOLECULES .3. HYDRATION OF POLYPEPTIDES [J].
KUNTZ, ID .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1971, 93 (02) :514-+
[38]   Charge Shielding Prevents Aggregation of Supercharged GFP Variants at High Protein Concentration [J].
Laber, Joshua R. ;
Dear, Barton J. ;
Martins, Matheus L. ;
Jackson, Devin E. ;
DiVenere, Andrea ;
Gollihar, Jimmy D. ;
Ellington, Andrew D. ;
Truskett, Thomas M. ;
Johnston, Keith P. ;
Maynard, Jennifer A. .
MOLECULAR PHARMACEUTICS, 2017, 14 (10) :3269-3280
[39]  
LAI PH, 1986, J BIOL CHEM, V261, P3116
[40]   Clustal W and clustal X version 2.0 [J].
Larkin, M. A. ;
Blackshields, G. ;
Brown, N. P. ;
Chenna, R. ;
McGettigan, P. A. ;
McWilliam, H. ;
Valentin, F. ;
Wallace, I. M. ;
Wilm, A. ;
Lopez, R. ;
Thompson, J. D. ;
Gibson, T. J. ;
Higgins, D. G. .
BIOINFORMATICS, 2007, 23 (21) :2947-2948